Description:

RTOG 0825 Phase III GBM Salvage Treatment Summary Form (SF) Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5AE2A23C-8AF1-6A8B-E044-0003BA3F9857

Lien:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5AE2A23C-8AF1-6A8B-E044-0003BA3F9857
Mots-clés:
  1. 26/08/2012 26/08/2012 -
  2. 09/01/2015 09/01/2015 - Martin Dugas
  3. 09/01/2015 09/01/2015 - Martin Dugas
  4. 09/01/2015 09/01/2015 - Martin Dugas
Téléchargé le:

9 janvier 2015

DOI:
Pour une demande vous connecter.
Licence :
Creative Commons BY-NC 3.0 Legacy
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Brain and Central Nervous System Tumors NCT00884741 Treatment - RTOG 0825 Phase III GBM Salvage Treatment Summary Form (SF) - 2797440v1.0

INSTRUCTIONS: Submit this form at the completion of each cycle of salvage treatment. Dates are to be recorded as mm-dd-yyyy unless otherwise specified

Module 1
Amended Data (INSTRUCTIONS: Complete form on web to unblind the protocol treatment arm)
Assessment
cm
Kg
m2
Karnofsky Performance Status (Use 9 if unknown)
Neurologic function
Disease Progression
Salvage treatment being reported
Is protocol chemotherapy continuing?
Unnamed 3
Was dose reduced more than 20%
Reason for Treatment Modification
Reason Treatment Ended
Protocol Specific Adverse Event Evaluation
Were there any hemorrhage events during this report period
CTC AE Attribution Code
CTC AE Attribution Code
SAE report submitted
SAE report submitted
seconds
seconds
seconds
seconds
seconds
1000/uL
Protocol Specific Adverse Event Evaluation
Were there any study-specific adverse events during this report period
CTC AE Attribution Code
SAE report submitted
Protocol Specific Adverse Event Evaluation
Any Treatment Related Adverse Events
CTC AE Attribution Code
SAE report submitted
Footer Module

Similar models

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial